Compare · MCK vs WGRX
MCK vs WGRX
Side-by-side comparison of McKesson Corporation (MCK) and Wellgistics Health Inc. (WGRX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MCK and WGRX operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- MCK is the larger of the two at $101.08B, about 10847.6x WGRX ($9.3M).
- Over the past year, MCK is up 18.2% and WGRX is down 92.2% - MCK leads by 110.4 points.
- MCK has been more active in the news (15 items in the past 4 weeks vs 7 for WGRX).
- MCK has more recent analyst coverage (25 ratings vs 0 for WGRX).
- Company
- McKesson Corporation
- Wellgistics Health Inc.
- Price
- $841.14+1.99%
- $3.52+27.72%
- Market cap
- $101.08B
- $9.3M
- 1M return
- +9.73%
- +2.47%
- 1Y return
- +18.20%
- -92.23%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2025
- News (4w)
- 15
- 7
- Recent ratings
- 25
- 0
McKesson Corporation
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Latest MCK
- McKesson Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form 4 filed by Director Hinton James H.
- SEC Form 4 filed by Director Doughtie Lynne M
- Director Wilson-Thompson Kathleen was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)
- SEC Form 4 filed by Director Dunbar Webster Roy
- Director Caruso Dominic J was granted 277 shares, increasing direct ownership by 43% to 927 units (SEC Form 4)
- SEC Form 4 filed by Director Gerberding Julie L.
- SEC Form 4 filed by Director Lerman Bradley E
- Director Martinez Maria was granted 277 shares, increasing direct ownership by 92% to 578 units (SEC Form 4)
- SEC Form 4 filed by Director Ozan Kevin M
Latest WGRX
- DataMEDS AI Officially Begins Trading Under Stock Symbol 'MEDS' on the NASDAQ Capital Markets
- Wellgistics Health Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC.
- Wellgistics Health Announces Updated Record Date for Distribution of Dream Bowl 2026 Meme Coin to Stockholders
- Rubenstein Public Relations Named Agency of Record for Wellgistics Health, Inc.
- Wellgistics Health Appoints Brett Thompson as Chief Technology Officer
- Wellgistics Health Executive Chairman and President Exercise Warrants
- DataMeds AI, Inc. Selected as Proposed New Name for Wellgistics Health, Inc.
- Director Ajjarapu Surendra K exercised 100,000 in-the-money shares at a strike of $0.01, increasing direct ownership by 63% to 257,645 units (SEC Form 4)
- Chief Executive Officer Patel Prashant exercised 100,000 in-the-money shares at a strike of $0.01, increasing direct ownership by 55% to 282,365 units (SEC Form 4)